Skip to main content

Table 2 Laboratory findings of patients infected with COVID-19 on admission to hospital

From: Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak

  Total
(n = 156)
Survivor
(n = 100)
Non-survivor
(n = 56)
P valuea
WBC count, 109/L 6.2 (4.7–8.3) 5.6 (4.5–7.2) 7.8 (5.5–12.6) < 0.001
Neutrophil count, 109/L 4.0 (3.0–6.8) 3.4 (2.5–5.0) 6.8 (4.5–11.3) < 0.001
Lymphocyte count, 109/L 1.2 (0.7–1.7) 1.4 (1.0–1.9) 0.7 (0.5–1.1) 0.503
NEU (%), % 71.0 (58.9–84.4) 62.9 (55.3–72.4) 86.7 (76.3–91.0) < 0.001
LYM (%), % 19.7 (10.5–30.6) 27.6 (18.4–33.5) 8.7 (4.7–14.3) < 0.001
Hemoglobin, g/L 123.7 (114.2–136.6) 125.0 (115.5–136.3) 122.4 (113.9–135.8) 0.246
Platelet, 109/L 194.0 (157.0–249.0) 218.5 (172.3–259.5) 168.0 (114.0–200.0) < 0.001
Total bilirubin, mmol/L 10.9 (7.5–17.2) 10.7 (7.5–14.6) 13.0 (7.5–25.6) 0.057
LDH, U/L 197.0 (159.5–279.0) 175.0 (149.0–219.0) 310.5 (201.0–479.3) < 0.001
ALT, U/L 20.2 (13.5–39.5) 19.5 (13.0–37.9) 22.1 (14.7–41.5) 0.400
AST, U/L 21.7 (16.1–34.2) 18.8 (15.1–26.6) 30.0 (21.3–55.3) 0.002
Albumin, g/L 37.5 (33.8–42.6) 39.9 (36.5–43.3) 33.1 (29.7–33.6) < 0.001
Globulin, g/L 28.7 (24.4–32.9) 28.2 (24.1–30.9) 31.5 (24.8–34.9) 0.014
BUN, mmol/L 4.7 (3.7–6.2) 4.2 (3.3–5.3) 6.2 (5.0–10.8) < 0.001
Creatinine, μmol/L 66.1 (50.3–84.2) 64.8 (50.9–75.1) 74.2 (47.0–126.9) 0.008
CK, U/L 68.0 (45.0–121.0) 63.0 (40.0–96.0) 112.8 (62.3–245.0) 0.028
CK-MB, U/L 1.6 (0.8–4.6) 0.9 (0.7–1.4) 4.3 (1.7–13.3) 0.044
troponin I, pg/ml 20.0 (4.1–57.5) 10.0 (3.0–20.0) 50.0 (22.3–115.0) 0.013
BNP, ng/L 118.5 (32.5–392.7) 56.8 (20.0–132.9) 374.7 (135.1–814.5) 0.069
D-dimer, mg/L 1.0 (0.4–4.6) 0.7 (0.2–1.6) 3.3 (1.2–7.8) 0.025
CRP, mg/L 0.9 (0.1–3.6) 0.2 (0.1–1.6) 4.1 (2.5–7.2) < 0.001
Procalcitonin, ng/mL 0.06 (0.04–0.14) 0.05 (0.04–0.06) 0.37 (0.12–0.77) 0.022
IL-6, pg/mL 7.1 (2.4–24.7) 2.9 (1.5–7.4) 79.6 (9.6–212.5) 0.027
CD19+, count/μL 12.6 (9.0–18.9) 11.1 (8.6–17.0) 16.6 (10.1–19.1) 0.292
CD3+, count/μL 68.9 (57.4–75.3) 70.6 (62.0–76.7) 66.8 (54.6–71.4) 0.329
CD4+, count/μL 38.8 (34.6–46.0) 38.8 (31.4–45.2) 39.4 (36.2–52.5) 0.183
CD8+, count/μL 25.3 (19.2–32.3) 26.7 (19.6–33.9) 20.5 (13.9–30.5) 0.063
CD4/CD8 1.6 (1.1–2.3) 1.5 (1.0–2.1) 1.8 (1.2–3.9) 0.071
  1. Notes: Data presented as n (%) or median (IQR)
  2. Abbreviations: COVID-19 Coronavirus Disease 2019, WBC White blood cell, NEU (%) Percentage of neutrophils, LYM (%) Percentage of lymphocytes, LDH Lactate dehydrogenase, ALT Alanine aminotransferase, AST Aspartate aminotransferase, BUN Blood urea nitrogen, CK Creatine kinase-MB, CK-MB Creatine kinase-MB, BNP Brain natriuretic peptide, CRP C-reactive protein, IL-6,Interleukin-6
  3. aP values indicate differences between survivors and non-survivors. P < 0.05 was considered statistically significant